1. (a) Before providing medication assisted opioid use disorder services through a stand-alone medication unit, the program must receive the written approval of both SAMHSA and ODMHSAS, and ODMHSAS certification, OBNDD approval, and national accreditation. A mobile medication unit must have an associated OTP physical location for purposes of ODMHSAS certification.
2. (b) Any services that are provided in an OTP may be provided in the medication unit, assuming compliance with all applicable Federal, State, and local law, and the use of units that provide appropriate privacy and have adequate space.

3. (c) Medication units shall be in compliance with the following:

   1. (1) Currently licensed by the DEA; and approved by SAMHSA.
   2. (2) Written policy and procedure stating the medical director shall make all recommendations for medication dosages according to best medical practice guidelines and all applicable rules contained in this chapter.
   3. (3) Written policy and procedure stating all female consumers shall have a pregnancy test on admission and at least annually thereafter, unless otherwise indicated.
   4. (4) Written policy and procedure to address the provision of all services in compliance with Federal Drug Administration Guidelines for opioid treatment programs in accordance with 42 CFR, Part 8.

4. (d) Compliance with 450:70-6-10 may be determined by:

   1. (1) A review of policies and procedures,
   2. (2) Certifications and licenses, and
   3. (3) Other facility documentation.

Added at 24 Ok Reg 2634, eff 7-12-07

Amended at 30 Ok Reg 1425, eff 7-1-13

Amended at 34 Ok Reg 1830, eff 10-1-17

Amended at 39 Ok Reg 2017, eff 9-15-22

Amended at 40 Ok Reg 1079, eff 9-15-23

Amended at 42 Ok Reg, Number 20, effective 9-1-25